Tyrosine-protein kinase transforming protein Src

BE0004321ProteinRSV-SRAV-SRC

This phosphoprotein, required for both the initiation and the maintenance of neoplastic transformation, is a protein kinase that catalyzes the phosphorylation of tyrosine residues in vitro. It is acted on by 1 drug in DrugBank.

Gene name
V-SRC
UniProtKB entry
P00524Swiss-Prot
Residues / weight
526 residues · 58,877 Da
Also known as
2.7.10.2 · p60-Src · pp60v-src · v-Src

Resolves to

Protein
UniProtP00524UniProt nameSRC_RSVSA
Gene
GenBank459676
Structure
PDB1BKLPDB1BKMPDB1IS0
Drugs

What you can answer from here — as of September 07, 2019

1DrugApproved to experimental, with action, bond type and pharmacological action
Sign in
2GO termsFunction, process and component, as structured annotations
Sign in
1Pfam domainDomain architecture mapped to Pfam families and clans
Sign in
11+ReferencesStructured and connected to the statements they support
Sign in

Which compounds in development act on Tyrosine-protein kinase transforming protein Src, and which indications are they being tested in?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In